7,921 results match your criteria Raynaud Phenomenon

Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: One-year follow-up.

Semin Arthritis Rheum 2022 Jul 9;56:152065. Epub 2022 Jul 9.

Department of Internal Medicine, division Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Objective: Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after single-port thoracoscopic sympathicotomy (SPTS).

Methods: Eight patients (six males, two females, median age of 45 years) with treatment-resistant RP underwent left-sided SPTS at the third rib (R3), unilaterally. Questionnaires were taken, and number and duration of RP attacks were reported over a 2-week period. Read More

View Article and Full-Text PDF

Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections.

JAAD Case Rep 2022 Aug 30;26:79-81. Epub 2022 Jun 30.

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

View Article and Full-Text PDF

Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction.

Int J Clin Pract 2022 18;2022:7025811. Epub 2022 Jul 18.

Department of Physiotherapy, Zaozhuang Municipal Hospital, Zaozhuang 277000, China.

Objective: The present study aims to (1) analyze the clinical characteristics and related influencing factors of knee bone infarction in systemic lupus erythematosus (SLE) and (2) improve the understanding of SLE complicated with knee bone infarction.

Methods: The data of patients with SLE complicated with knee bone infarction were retrospectively analysed; patients with SLE during the same period who matched in age, gender, and disease duration were selected as control subjects, with a 1 : 1 ratio with the SLE group. The clinical data were collected to analyze the risk factors for SLE complicated with knee bone infarction. Read More

View Article and Full-Text PDF

[Functional vascular acrosyndromes].

Inn Med (Heidelb) 2022 Jun 16;63(6):591-600. Epub 2022 May 16.

Poliklinik und Funktionsbereich für Rheumatologie & Hiller-Forschungszentrum für Rheumatologie, Universitätsklinikum Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.

Vascular acrosyndromes are characterized by sparse, uniform clinical manifestations and a variety of possible pathomechanisms. The present article focuses on the functional entities. Raynaud phenomenon is based on cold- or stress-induced vasospasms of acral arteries. Read More

View Article and Full-Text PDF

Association of Clinical Manifestations of Systemic Lupus Erythematosus and Complementary Therapy Use in Taiwanese Female Patients: A Cross-Sectional Study.

Medicina (Kaunas) 2022 Jul 17;58(7). Epub 2022 Jul 17.

Graduate Institute of Long-Term Care, Tzu Chi University of Science and Technology, Hualien City 970302, Taiwan.

: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that affects predominantly women in the childbearing years. Patients may seek complementary therapies to manage their health and to reduce symptoms. However, to our knowledge, no studies have explored the association between clinical manifestations of SLE and complementary therapies. Read More

View Article and Full-Text PDF

Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient.

Case Reports Immunol 2022 12;2022:8541329. Epub 2022 Jul 12.

Isfahan Cardiovascular Research Center (Heart Failure Research Center), Isfahan, Iran.

Systemic sclerosis (SSC) is an autoimmune disease of connective tissue and microvasculature mostly caused by autoantibodies. Likewise, neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system correlating with autoantibodies against aquapourin-4. Reversible cerebral vasoconstriction syndrome (RCVS) is a disorder of brain vasculature resembling Raynaud phenomena in SSC. Read More

View Article and Full-Text PDF

Incidence, remission, and persistence of Raynaud's phenomenon in the general population of northern Sweden: a prospective study.

BMC Rheumatol 2022 Jul 21;6(1):41. Epub 2022 Jul 21.

Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, 901 87, Umeå, Sweden.

Background: Raynaud's phenomenon is common condition, but little is known about the natural course. The primary aim of this study was to determine the incidence, remission, and persistence proportions of Raynaud's phenomenon in the general population of northern Sweden. Secondary aims were to determine how individual and exposure factors affect the course of Raynaud's phenomenon, and to assess gender differences. Read More

View Article and Full-Text PDF

Raynaud's Phenomenon and Limb Hypertrophy Presenting Phacomatosis Pigmentovascularis: A Rare Association.

Cureus 2022 Jun 13;14(6):e25900. Epub 2022 Jun 13.

Anesthesia and Critical Care, Jaipur National University (JNU) Hospital, Jaipur, IND.

Phacomatosis pigmentovascularis is a rare dermal disorder attributed to the presence of various nevi. These lesions exist since birth, so the patient remains well aware of them. Various systemic involvements may be associated with the nevus, but the association of Raynaud's phenomenon is seldom reported. Read More

View Article and Full-Text PDF

[Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management].

P Senet

Rev Med Interne 2022 Jul 11. Epub 2022 Jul 11.

Service de dermatologie, hôpital Tenon, 4, rue de la Chine, 75970 Paris cedex 20, France. Electronic address:

Paroxysmal vascular acrosyndromes are related to a peripheral vasomotor disorder and presented as paroxysmal color changes of the fingers. They include primary Raynaud's phenomenon (RP), which is the most common, secondary RP and erythermalgia. They are to be distinguished from non-paroxysmal acrosyndromes such as acrocyanosis and chilblains, which are very frequent and often associated with RP, digital ischemia and necrosis, spontaneous digital hematoma and acrocholosis. Read More

View Article and Full-Text PDF

Nailfold video capillaroscopy as a useful diagnostic tool in systemic vasculitis.

Microvasc Res 2022 Sep 11;143:104406. Epub 2022 Jul 11.

Rheumatology Unit, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel. Electronic address:

Background: Nailfold video capillaroscopy (NVC) enables us a direct view of the microvasculature. Only several capillaroscopy studies in adult patients with vasculitis have been reported.

Aim: To characterize NVC changes in vasculitis. Read More

View Article and Full-Text PDF
September 2022

The safety and persistence of intravenous iloprost in systemic sclerosis.

ARP Rheumatol 2022 Apr-Jun;1(2):122-128

Serviço de Reumatologia e Doenças Ósseas Metabólicas, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte.

Introduction: Vasculopathy is a crucial feature of systemic sclerosis (SSc). It occurs in almost every patient with SSc, with Raynaud's phenomenon (RP) and digital ulcers (DU) having a great impact on the quality of patients' lives. Intravenous (IV) iloprost, a synthetic analogue of prostacyclin, is broadly used to treat RP and DU secondary to SSc. Read More

View Article and Full-Text PDF

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.

Respir Res 2022 Jul 5;23(1):178. Epub 2022 Jul 5.

Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Background: The forced vital capacity (FVC) of healthy individuals depends on their age, sex, ethnicity and height. Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is characterised by loss of FVC. We compared FVC values in the subjects with SSc-ILD in the SENSCIS trial of nintedanib versus placebo with values from hypothetical matched healthy references. Read More

View Article and Full-Text PDF

Adult and child and adolescent psychiatrists' experiences of transition in anorexia nervosa: a qualitative study.

J Eat Disord 2022 Jul 4;10(1):92. Epub 2022 Jul 4.

Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, CHU de Toulouse, Hôpital Purpan, Place du Dr Baylac, TSA 40031, 31059, Toulouse cedex 9, France.

Background: Young patients suffering from anorexia nervosa (AN) frequently need further treatment in Adult Mental Health Services (AMHS). The transition period from Child and Adolescent Mental Health Services (CAMHS) to AMHS is a critical time, with a high risk of disengagement from healthcare. We explored physicians' perspectives of the transition to triangulate the multiple perspectives of physicians, parents and those with a lived AN experience to more comprehensively characterize the challenges in this process of treatment transition. Read More

View Article and Full-Text PDF

Raynaud Phenomenon: Angiographic Appearances of Reversible Vasoconstriction.

J Clin Rheumatol 2022 Jun 30. Epub 2022 Jun 30.

Department of Radiology, Monash Health, Melbourne, Australia.

View Article and Full-Text PDF

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review.

Chin Med J (Engl) 2022 05 5;135(9):1133-1134. Epub 2022 May 5.

Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.

View Article and Full-Text PDF

Teriflunomide-induced Raynaud's phenomenon: a serious adverse event, previously unreported.

Neurol Sci 2022 Jun 29. Epub 2022 Jun 29.

Service of Rheumatology, Hospital Sierrallana, IDIVAL, Torrelavega, Spain.

View Article and Full-Text PDF

Social Isolation Among Older Adults in the Time of COVID-19: A Gender Perspective.

Front Public Health 2022 9;10:840940. Epub 2022 Jun 9.

IRIS, Inserm/EHESS, Aubervilliers, France.

We aimed to analyze inequalities in social isolation among older adults in a time of COVID-19 social restrictions, using a gender perspective. A random population-based survey, including 21,543 older adults (65+) was conducted during and post COVID-19 lockdown in France. Our main outcome was a three-dimension indicator of social isolation based on living conditions, i. Read More

View Article and Full-Text PDF

Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article.

Toxins (Basel) 2022 06 14;14(6). Epub 2022 Jun 14.

Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

The normal biological wound healing process consists of three precisely and highly programmed phases that require optimal conditions including internal and external factors. Any negative factors that disrupt the sequence or time frame of the healing mechanism can result in a non-healing wound or chronic ulcers. Botulinum neurotoxin A (BoNT-A) which is generally known as anti-contraction of muscles has been reported as a successful treatment in various types of chronic ulcers. Read More

View Article and Full-Text PDF

Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163.

Immunol Lett 2022 Aug 18;248:56-61. Epub 2022 Jun 18.

Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ismael Cosío Villegas, Calz. Tlalpan 4502, Sección XVI, Tlalpan, México City, Ciudad de México 14080, Mexico; Profesor, Programa de Maestría y Doctorado en Ciencias Médicas, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 14080, Mexico. Electronic address:

Background: Patients with anti-tRNA autoantibodies are characterized by arthritis, mechanic´s hands, fever, Raynaud´s phenomenon, and interstitial lung disease (ILD), in at least two clinical scenarios: the antisynthetase syndrome (ASSD) and interstitial pneumonia with autoimmune features (IPAF). The anti-tRNA-ILD treatment is centered on the administration of corticosteroids and a wide variety of immunosuppressive drugs; however, the effectiveness of the treatment depends on factors not fully understood. This research work aimed to quantify the serum levels of two molecules related to pulmonary fibrosis and explore their relationship with the progression of ILD associated with ASSD METHODOLOGY: Serum levels of sCD163 and TGF-β1 from baseline and after six months of treatment of ILD patients' positives to anti-tRNA were included in the current study. Read More

View Article and Full-Text PDF

Practical management of Raynaud's phenomenon - a primer for practicing physicians.

Curr Opin Rheumatol 2022 07 9;34(4):235-244. Epub 2022 Jun 9.

Division of Rheumatology, Department of Medicine.

Purpose Of Review: Raynaud's phenomenon (RP) is a common vasospastic condition that results in digital hypoperfusion in response to cold and/or emotional stress and is associated with significant pain and disability. The aim of our review is to provide a practical approach for clinicians to inform assessment and management of patients with RP.

Recent Findings: Autoantibodies and nailfold capillaroscopy are key investigations to stratify the risk of progression to systemic sclerosis (SSc) in patients RP, which was recently confirmed in the multicenter, very early diagnosis of systemic sclerosis (VEDOSS) project. Read More

View Article and Full-Text PDF

Systemic sclerosis in Native Americans of the American Southwest.

Int J Rheum Dis 2022 Jun 14. Epub 2022 Jun 14.

Division of Rheumatology and School of Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.

Objective: Many indigenous non-Caucasian populations, including Native Americans, have been reported to have higher rates, distinct clinical phenotypes, increased complications, and greater severity of systemic sclerosis (SSc). However, little is known of SSc specifically in Native Americans of the American Southwest. This study compared the clinical and serologic manifestations and outcomes of SSc in Native Americans and non-Native Americans (non-Natives) of this region. Read More

View Article and Full-Text PDF

The Association of Flow-Mediated Dilatation and Blood Parameters in Primary Raynaud's Phenomenon.

Int J Clin Pract 2022 31;2022:9347946. Epub 2022 Jan 31.

Department of Cardiovascular Surgery, Tokat State Hospital, Tokat, Turkey.

Introduction: Raynaud's phenomenon (RP) is a multifactorial disorder. If any underlying disease cannot be determined to be responsible for RP, then it is considered to be the primary RP (pRP). We aimed to investigate the differences between laboratory markers and impaired endothelial function in pRP. Read More

View Article and Full-Text PDF

The impact of Raynaud's phenomenon on work ability - a longitudinal study.

J Occup Med Toxicol 2022 Jun 8;17(1):12. Epub 2022 Jun 8.

Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, 901 87, Umeå, Sweden.

Objective: To determine if having Raynaud's phenomenon (RP) affects the work ability, job retainment, or occurrence of sick leave.

Methods: Surveys on the working-age general population of northern Sweden were conducted in 2015 and 2021, gathering data on RP, occupation and sick leave. Work ability was assessed using the Work Ability Score. Read More

View Article and Full-Text PDF

Is there any Sympathetic Skin Response Abnormality in Raynaud Phenomenon?

Sultan Qaboos Univ Med J 2022 May 26;22(2):274-279. Epub 2022 May 26.

Department of Biostatics and Epidemiology, Babol University of Medical Science, Babol, Iran.

Objectives: This study aimed to evaluate sympathetic skin response (SSR) among patients with Raynaud phenomenon (RP). SSR is a technique for assessment of the damage of peripheral neuropathies and the disorders of the sympathetic system.

Methods: Between January 2015 and December 2018, approximately 20 patients with RP and 20 healthy subjects (control group) were recruited from patients referred to the outpatient clinics of Shiraz University of Medical Sciences, Shiraz, Iran. Read More

View Article and Full-Text PDF

Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registry.

ARP Rheumatol 2022 Jan-Mar;1(1):21-29

Serviço de Reumatologia, Hospital Garcia de Orta; Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa.

Background: Systemic sclerosis (SSc) is a rare connective tissue disorder with heterogeneous manifestations and outcomes. Besides differences in disease characteristics among distinct ethnic groups and geographical regions, several questions regarding the impact of the disease and the effectiveness of treatments remain unanswered. To address these questions, the Rheumatic Diseases Portuguese Register (Reuma. Read More

View Article and Full-Text PDF

Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.

Molecules 2022 May 13;27(10). Epub 2022 May 13.

Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Botulinum toxin (BoNT) is a neurotoxin produced by the bacteria. Among seven different isoforms, only BoNT-A and BoNT-B are commercially used. Currently, botulinum toxin has been indicated by the U. Read More

View Article and Full-Text PDF

Clinical Issues-June 2022.

Emily Jones

AORN J 2022 06;115(6):577-584

Electrostatic precipitator device use during laparoscopic surgery Key words: electrostatic precipitation (ESP), surgical smoke precipitator, anions, visual field, medical device reporting (MDR). Removal of used flammable skin antisepsis materials Key words: flammable liquid antiseptics, National Fire Protection Association (NFPA), fire prevention, fire risk, patient care vicinity. Ocular protection for patients with eyelash extensions Key words: ocular injury, eyelash extensions, eye protection, lagophthalmos, intraocular pressure. Read More

View Article and Full-Text PDF

Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.

J Scleroderma Relat Disord 2022 Jun 21;7(2):144-150. Epub 2022 Apr 21.

Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.

Background: The utility of nailfold capillaroscopy in the evaluation of patients without Raynaud's phenomenon is unclear.

Objective: This study aims to compare the utility of nailfold capillaroscopy for the early diagnosis of the scleroderma-spectrum of diseases in patients who present with Raynaud's phenomenon, undifferentiated non-Raynaud's phenomenon features and positive systemic sclerosis-associated antibodies without scleroderma-spectrum of disease features.

Methods: Eligible patients were divided into three referral criteria groups: (I) Raynaud's phenomenon; (II) Undifferentiated non-Raynaud's phenomenon features and (III) Positive systemic sclerosis-associated autoantibodies without features to suggest scleroderma-spectrum of diseases. Read More

View Article and Full-Text PDF

Raynaud's phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report.

BMC Rheumatol 2022 May 19;6(1):26. Epub 2022 May 19.

Internal Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.

Background: POEMS syndrome is a rare paraneoplastic syndrome caused by plasma cell disorder almost always lambda restricted. Secondary Raynaud's phenomenon is an overlooked skin manifestation of the disease even though it is present in twenty percent of patients. On POEMS syndrome have not been described positive antinuclear antibodies (ANA) and this could lead to a misdiagnosis of autoimmune disease, mainly systemic sclerosis. Read More

View Article and Full-Text PDF

[Aspergillus mediastinitis following post-immunotherapy lobectomy for oligometastatic lung].

Rev Mal Respir 2022 May 12;39(5):498-501. Epub 2022 May 12.

Service de chirurgie thoracique et vasculaire, hôpital Victor-Dupouy, 69, rue du Lieutnant-Colonel Prudhon, 95107 Argenteuil, France. Electronic address:

The relationship between infectious disease and therapy with immune checkpoint inhibitors remains unknown. We report the case of a 50-year-old woman with metastatic lung adenocarcinoma who responded remarkably well to immunotherapy and underwent upper right lobectomy. Three weeks after hospital discharge, she was readmitted for severe dyspnea due to mainstem bronchus compression by mediastinal mass. Read More

View Article and Full-Text PDF